|
1
|
Thompson LD: Osteosarcoma. Ear Nose Throat
J. 92:288–290. 2013.PubMed/NCBI
|
|
2
|
Liang W, Gao B, Fu P, Xu S, Qian Y and Fu
Q: The miRNAs in the pathgenesis of osteosarcoma. Front Biosci
(Landmark Ed). 18:788–794. 2013. View
Article : Google Scholar
|
|
3
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen L, Wang P, Yang J and Li X:
MicroRNA-217 regulates WASF3 expression and suppresses tumor growth
and metastasis in osteosarcoma. PLoS One. 9:e1091382014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Q, Cai J, Wang J, Xiong C and Zhao J:
miR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.
Tumour Biol. 35:12743–12748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang L, He A, Zhang Q and Tao C: miR-126
inhibits cell growth, invasion, and migration of osteosarcoma cells
by downregulating ADAM-9. Tumour Biol. 35:12645–12654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang K, Zhang Y, Ren K, Zhao G, Yan K and
Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by
downregulation of EZH2 expression. Oncol Rep. 32:2143–2149.
2014.PubMed/NCBI
|
|
8
|
Han K, Zhao T, Chen X, Bian N, Yang T, Ma
Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses
osteosarcoma cell proliferation and metastasis in vitro and in vivo
by targeting CDH2 and IGF1R. Int J Oncol. 45:1437–1449.
2014.PubMed/NCBI
|
|
9
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sundaram MV: Canonical RTK-Ras-ERK
signaling and related alternative pathways. Jul 11–2013, pp. 1–38.
View Article : Google Scholar
|
|
11
|
Jiménez G, Shvartsman SY and Paroush Z:
The Capicua repressor - a general sensor of RTK signaling in
development and disease. J Cell Sci. 125:1383–1391. 2012.
View Article : Google Scholar
|
|
12
|
Batchu SN and Korshunov VA: Novel tyrosine
kinase signaling pathways: Implications in vascular remodeling.
Curr Opin Nephrol Hypertens. 21:122–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
DeChiara TM, Kimble RB, Poueymirou WT,
Rojas J, Masiakowski P, Valenzuela DM and Yancopoulos GD: Ror2,
encoding a receptor-like tyrosine kinase, is required for cartilage
and growth plate development. Nat Genet. 24:271–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehawej C, Chouery E, Maalouf D, Baujat G,
Le Merrer M, Cormier-Daire V and Mégarbané A: Identification of a
novel causative mutation in the ROR2 gene in a Lebanese family with
a mild form of recessive Robinow syndrome. Eur J Med Genet.
55:103–108. 2012. View Article : Google Scholar
|
|
15
|
Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D,
Yan CM, Wang DJ and Sun JY: Expression of WNT-5a and ROR2
correlates with disease severity in osteosarcoma. Mol Med Rep.
5:1033–1036. 2012.PubMed/NCBI
|
|
16
|
Ren D, Minami Y and Nishita M: Critical
role of Wnt5a-Ror2 signaling in motility and invasiveness of
carcinoma cells following Snail-mediated epithelial-mesenchymal
transition. Genes Cells. 16:304–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Enomoto M, Hayakawa S, Itsukushima S, Ren
DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, et
al: Autonomous regulation of osteosarcoma cell invasiveness by
Wnt5a/Ror2 signaling. Oncogene. 28:3197–3208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang YJ, Wang QY, Zhou CX, Yin QQ, He M,
Yu XT, Cao DX, Chen GQ, He JR and Zhao Q: miR-124 targets Slug to
regulate epithelial-mesenchymal transition and metastasis of breast
cancer. Carcinogenesis. 34:713–722. 2013. View Article : Google Scholar :
|
|
19
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
20
|
An L, Liu Y, Wu A and Guan Y: microRNA-124
inhibits migration and invasion by down-regulating ROCK1 in glioma.
PLoS One. 8:e694782013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Y, Meng C, Shao Z, Wang H and Yang S:
miR-23a functions as a tumor suppressor in osteosarcoma. Cell
Physiol Biochem. 34:1485–1496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang F, Huang W, Sheng M and Liu T:
miR-451 inhibits cell growth and invasion by targeting CXCL16 and
is associated with prognosis of osteosarcoma patients. Tumour Biol.
36:2041–2048. 2015. View Article : Google Scholar
|
|
24
|
Lin S, Shao NN, Fan L, Ma XC, Pu FF and
Shao ZW: Effect of microRNA-101 on proliferation and apoptosis of
human osteosarcoma cells by targeting mTOR. J Huazhong Univ Sci
Technolog Med Sci. 34:889–895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han G, Wang Y, Bi W, Jia J and Wang W:
MicroRNA-124 functions as a tumor suppressor and indicates
prognosis in human osteosarcoma. Exp Ther Med. 9:679–684.
2015.PubMed/NCBI
|
|
26
|
Geng S, Zhang X, Chen J, Liu X, Zhang H,
Xu X, Ma Y, Li B, Zhang Y, Bi Z, et al: The tumor suppressor role
of miR-124 in osteosarcoma. PLoS One. 9:e915662014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stricker S and Mundlos S: FGF and ROR2
receptor tyrosine kinase signaling in human skeletal development.
Curr Top Dev Biol. 97:179–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Bhat RA, Seestaller-Wehr LM,
Fukayama S, Mangine A, Moran RA, Komm BS, Bodine PV and Billiard J:
The orphan receptor tyrosine kinase Ror2 promotes osteoblast
differentiation and enhances ex vivo bone formation. Mol
Endocrinol. 21:376–387. 2007. View Article : Google Scholar
|
|
29
|
Liu Y, Ross JF, Bodine PV and Billiard J:
Homodimerization of Ror2 tyrosine kinase receptor induces
14-3-3(beta) phosphorylation and promotes osteoblast
differentiation and bone formation. Mol Endocrinol. 21:3050–3061.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamagata K, Li X, Ikegaki S, Oneyama C,
Okada M, Nishita M and Minami Y: Dissection of Wnt5a-Ror2 signaling
leading to matrix metalloproteinase (MMP-13) expression. J Biol
Chem. 287:1588–1599. 2012. View Article : Google Scholar :
|
|
31
|
Morioka K, Tanikawa C, Ochi K, Daigo Y,
Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, et
al: Orphan receptor tyrosine kinase ROR2 as a potential therapeutic
target for osteosarcoma. Cancer Sci. 100:1227–1233. 2009.
View Article : Google Scholar : PubMed/NCBI
|
